Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults

NCT: NCT06122675 · RECRUITING

NCT IDNCT06122675
StatusRECRUITING
Start Date2024-03-26
Completion2029-03-31
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with dyskinetic cerebral palsy will be implanted with a Medtronic Percept Primary Cell Neurostimulator. We will pilot videotaped automated movement recognition techniques and formal gait analysis, as well as collect and characterize each subject's physiological and neuroimaging markers that may predict hyperkinetic pathological states and their response to therapeutic DBS.

Frequently Asked Questions

What is Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults?

Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults is a clinical trial registered under NCT06122675. Current status: RECRUITING.

What is the status of NCT06122675?

The current status of NCT06122675 (Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults) is: RECRUITING.

When did Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults start?

Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults started on 2024-03-26.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.